Skip to main content
Premium Trial:

Request an Annual Quote

Innogenetics to Distribute Third Wave Invader Products in Europe

NEW YORK, April 27 (GenomeWeb News) - Third Wave Technologies, of Madison, Wisc., and Innogenetics, of Gent, Belgium, announced today that they have signed a four-year European marketing and distribution agreement for Third Wave Invader molecular diagnostic products.

 

Under the terms of the agreement, Innogenetics receives exclusive European marketing and distribution rights for select Invader products relating to genetic testing of risk factors for cardiovascular disease, blood coagulation, and healing disorders, the companies said.

 

In addition, the companies said, Innogenetics may distribute other new genetics-related tests developed by Third Wave in the future.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.